| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting the immune system. The company's therapeutic pipeline includes promising candidates such as GEM-AKI, which is being developed as a potential therapy for both the prevention and management of acute kidney injury, and GEM-CKD, intended for the prevention and treatment of chronic kidney disease. Established in 2019, this San Diego, California-based …
Over the last 12 months, insiders at Revelation Biosciences, Inc. have bought $0 and sold $0 worth of Revelation Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Revelation Biosciences, Inc. have bought $151,908 and sold $21,381 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 25,000 shares for transaction amount of $29,000 was made by TIDMARSH GEORGE F (director) on 2023‑04‑18.
| 2023-12-08 | Sale | TIDMARSH GEORGE F | director | 27,771 0.4059% | $0.52 | $14,438 | -88.63% | |
| 2023-10-16 | Sale | TIDMARSH GEORGE F | director | 12,802 0.1963% | $0.66 | $8,442 | -88.84% | |
| 2023-09-28 | Sale | TIDMARSH GEORGE F | director | 1,429 0.0232% | $0.69 | $986 | -88.58% | |
| 2023-09-18 | Sale | TIDMARSH GEORGE F | director | 4,000 0.0648% | $0.74 | $2,960 | -89.06% | |
| 2023-09-15 | Sale | TIDMARSH GEORGE F | director | 9,500 0.1449% | $0.73 | $6,935 | -89.52% | |
| 2023-09-14 | Sale | TIDMARSH GEORGE F | director | 12,000 0.1906% | $0.75 | $9,000 | -89.38% | |
| 2023-04-18 | TIDMARSH GEORGE F | director | 25,000 1.1925% | $1.16 | $29,000 | -37.85% | ||
| 2023-04-17 | TIDMARSH GEORGE F | director | 26,500 1.1885% | $1.16 | $30,740 | -41.40% | ||
| 2022-02-25 | TIDMARSH GEORGE F | 20,000 0.1609% | $1.60 | $32,000 | -64.16% | |||
| 2022-02-09 | TIDMARSH GEORGE F | 30,000 0.2157% | $2.55 | $76,599 | -77.69% | |||
| 2022-02-08 | TIDMARSH GEORGE F | 1,000 0.007% | $2.54 | $2,540 | -77.83% | |||
| 2022-02-07 | TIDMARSH GEORGE F | 42,100 0.2939% | $2.61 | $109,780 | -77.90% | |||
| 2022-02-04 | TIDMARSH GEORGE F | 9,900 0.0679% | $2.34 | $23,156 | -74.47% | |||
| 2021-09-23 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 611,541 4.7291% | $10.08 | $6.16M | -65.59% | |
| 2021-09-22 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 5 <0.0001% | $10.08 | $50 | -65.44% | |
| 2021-09-21 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 43,000 0.3323% | $10.08 | $433,440 | -65.46% | |
| 2020-11-09 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 5,000 0.0396% | $10.00 | $50,000 | ||
| 2020-10-12 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 20 0.0002% | $10.00 | $200 | ||
| 2020-10-09 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 9,328 0.0738% | $10.00 | $93,280 |
| Increased Positions | 13 | +216.67% | 236,223 | +248.59% |
| Decreased Positions | 3 | -50% | 23,143 | -24.35% |
| New Positions | 8 | New | 47,461 | New |
| Sold Out Positions | 3 | Sold Out | 23,143 | Sold Out |
| Total Postitions | 16 | +166.67% | 308,106 | +224.23% |
| Sabby Management, Llc | $168.00 | 3.45% | 207,051 | +185,122 | +844.19% | 2025-09-30 |
| Armistice Capital, Llc | $65.00 | 1.33% | 80,000 | +80,000 | New | 2025-09-30 |
| Drw Securities, Llc | $63.00 | 1.29% | 77,272 | +77,272 | New | 2025-09-30 |
| Jane Street Group, Llc | $12.00 | 0.25% | 14,764 | +14,764 | New | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $0 | 0.01% | 534 | -625 | -53.93% | 2025-09-30 |
| Sbi Securities Co., Ltd. | $0 | 0.01% | 458 | -932 | -67.05% | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | 0% | 14 | +11 | +366.67% | 2025-09-30 |
| Ubs Group Ag | $0 | 0% | 2 | -248 | -99.2% | 2025-09-30 |
| Citigroup Inc | $0 | 0% | 1 | +<1 | New | 2025-09-30 |
| Danske Bank A/S | $0 | 0% | 1 | +<1 | New | 2025-09-30 |